Show simple item record

Positive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substance

dc.contributor.authorLindkær-Jensen, Steen
dc.contributor.authorLarsen, Stig
dc.contributor.authorLindkær-Jensen, Nina Habib
dc.contributor.authorFagertun, Hans E.
dc.date.accessioned2015-08-10T12:34:09Z
dc.date.accessioned2015-08-21T11:41:44Z
dc.date.available2015-08-10T12:34:09Z
dc.date.available2015-08-21T11:41:44Z
dc.date.issued2015
dc.identifier.citationDrug Design, Development and Therapy 2015, 2015(9):1481-1490nb_NO
dc.identifier.issn1177-8881
dc.identifier.urihttp://hdl.handle.net/11250/297783
dc.description-nb_NO
dc.language.isoengnb_NO
dc.rightsNavngivelse 3.0 Norge*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/no/*
dc.titlePositive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substancenb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.date.updated2015-08-10T12:34:09Z
dc.identifier.doi10.2147/DDDT.S80451
dc.identifier.cristin1253339


Files in this item

Thumbnail
Name:
DDDT-80451.pdf
Size:
1.309Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record

Navngivelse 3.0 Norge
Except where otherwise noted, this item's license is described as Navngivelse 3.0 Norge